Literature DB >> 31234236

Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.

Piers Blombery1,2,3, Richard W Birkinshaw4,5, Tamia Nguyen1,3, Jia-Nan Gong4,5, Ella R Thompson1,3, Zhen Xu4,5, David A Westerman1,2,3, Peter E Czabotar4,5, Michael Dickinson2,3, David C S Huang4,5, John F Seymour2,3, Andrew W Roberts2,4,5,6,7.   

Abstract

Entities:  

Keywords:  BCL2; genetic analysis; lymphomas

Mesh：

Substances：

Year:  2019        PMID： 31234236     DOI： 10.1111/bjh.16069

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  15 in total

Review 1.  Targeted Therapy in Chronic Lymphocytic Leukemia.

Authors:  Thomas J Kipps; Michael Y Choi
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

Review 2.  The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs.

Authors:  Sarah T Diepstraten; Mary Ann Anderson; Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Gemma L Kelly
Journal:  Nat Rev Cancer       Date:  2021-10-18       Impact factor: 60.716

3.  Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.

Authors:  Marie Wong; Chelsea Mayoh; Loretta M S Lau; David S Ziegler; Paul G Ekert; Mark J Cowley; Dong-Anh Khuong-Quang; Mark Pinese; Amit Kumar; Paulette Barahona; Emilie E Wilkie; Patricia Sullivan; Rachel Bowen-James; Mustafa Syed; Iñigo Martincorena; Federico Abascal; Alexandra Sherstyuk; Noemi A Bolanos; Jonathan Baber; Peter Priestley; M Emmy M Dolman; Emmy D G Fleuren; Marie-Emilie Gauthier; Emily V A Mould; Velimir Gayevskiy; Andrew J Gifford; Dylan Grebert-Wade; Patrick A Strong; Elodie Manouvrier; Meera Warby; David M Thomas; Judy Kirk; Katherine Tucker; Tracey O'Brien; Frank Alvaro; Geoffry B McCowage; Luciano Dalla-Pozza; Nicholas G Gottardo; Heather Tapp; Paul Wood; Seong-Lin Khaw; Jordan R Hansford; Andrew S Moore; Murray D Norris; Toby N Trahair; Richard B Lock; Vanessa Tyrrell; Michelle Haber; Glenn M Marshall
Journal:  Nat Med       Date:  2020-10-05       Impact factor: 53.440

Review 4.  Targeting apoptosis in cancer therapy.

Authors:  Benedito A Carneiro; Wafik S El-Deiry
Journal:  Nat Rev Clin Oncol       Date:  2020-03-23       Impact factor: 66.675

5.  DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition.

Authors:  Martijn Kerkhofs; Tamara Vervloessem; Kinga B Stopa; Victoria M Smith; Meike Vogler; Geert Bultynck
Journal:  Biomolecules       Date:  2020-07-21

6.  Prospects in the management of patients with follicular lymphoma beyond first-line therapy.

Authors:  David Qualls; Gilles Salles
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

7.  Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1.

Authors:  Stefania Fiorcari; Rossana Maffei; Claudio Giacinto Atene; Nicolò Mesini; Monica Maccaferri; Giovanna Leonardi; Silvia Martinelli; Ambra Paolini; Vincenzo Nasillo; Giulia Debbia; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

8.  Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death.

Authors:  Florian J Bock; Egor Sedov; Elle Koren; Anna L Koessinger; Catherine Cloix; Désirée Zerbst; Dimitris Athineos; Jayanthi Anand; Kirsteen J Campbell; Karen Blyth; Yaron Fuchs; Stephen W G Tait
Journal:  Nat Commun       Date:  2021-11-12       Impact factor: 14.919

Review 9.  Double agents of cell death: novel emerging functions of apoptotic regulators.

Authors:  Heather M Lamb
Journal:  FEBS J       Date:  2020-04-11       Impact factor: 5.542

10.  Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia.

Authors:  Xiang Zhang; Jiejing Qian; Huafeng Wang; Yungui Wang; Yi Zhang; Pengxu Qian; Yinjun Lou; Jie Jin; Honghu Zhu
Journal:  Biomark Res       Date:  2021-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.